Skip to main content
Clinical Trials/EUCTR2019-000959-14-FR
EUCTR2019-000959-14-FRActive, not recruitingPhase 1

The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motility disturbance in brain Injured PAtients. - NIPA

CHRU de Brest0 sites370 target enrollmentStarted: December 24, 2020Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
370

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 270
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

  • Not provided

Investigators

Sponsor
CHRU de Brest

Similar Trials